Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease

Journal of Immunology

Volumn 179, Issue 11, 2007, Pages 7376-7384

  Bahjat, Keith S ^a   Prell, Rodney A ^a   Allen, Heather E ^a   Liu, Weiqun ^a   Lemmens, Edward E ^a   Leong, Meredith L ^a   Portnoy, Daniel A ^b   Dubensky Jr , Thomas W ^a   Brockstedt, Dirk G ^a   Giedlin, Martin A ^a  

^a CERUS CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; INTERFERON; MONOCLONAL ANTIBODY; OKT 8; GAMMA INTERFERON; IMMUNOGLOBULIN RECEPTOR; LIGAND; NATURAL KILLER CELL ACTIVATING RECEPTORS; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL INFECTION; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CELL HOMING; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOLYSIS; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; INNATE IMMUNITY; INTRACELLULAR BACTERIUM; LISTERIA MONOCYTOGENES; LIVER CARCINOMA; LIVER TUMOR; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; TUMOR CELL LINE; TUMOR IMMUNITY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; DISEASE MODEL; IMMUNOLOGY; LISTERIOSIS; METHODOLOGY; MOUSE MUTANT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOTHERAPY; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIGANDS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC;

EID: 38849117087     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.11.7376     Document Type: Article

References (46)

1. Biron, C. A. 1999. Initial and innate responses to viral infections: pattern setting in immunity or disease. Curr. Opin. Microbiol. 2: 374-381.
2. Moretta, L., G. Ferlazzo, C. Bottino, M. Vitale, D. Pende, M. C. Mingari, and A. Moretta. 2006. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 214: 219-228.
3. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
4. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
5. Kim, S., K. Iizuka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3: 523-528.
6. Takeda, K., E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M. J. Smyth. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105: 2082-2089.
7. Yokoyama, W. M., S. Kim, and A. R. French. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22: 405-429.
8. Cretney, E., K. Takeda, H. Yagita, M. Glaccum, J. J. Peschon, and M. J. Smyth. 2002. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168: 1356-1361.
9. Lise, M., S. Mocellin, P. Pilati, and D. Nitti. 2005. Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. Front. Biosci. 10: 3042-3057.
10. Lewis, A. M., and R. C. Martin. 2006. The treatment of hepatic metastases in colorectal carcinoma. Am. Surg. 72: 466-473.
11. Lise, M., P. Pilati, P. Da Pian, S. Mocellin, D. Nitti, and S. Corazzino. 2003. Treatment options for liver metastases from colorectal cancer. J. Exp. Clin. Cancer Res. 22: 149-156.
12. Hayashi, S., H. Masuda, and M. Shigematsu. 1997. Liver metastasis rare in colorectal cancer patients with fatty liver. Hepatogastroenterology 44: 1069-1075.
13. Seymour K, and R. M. Charnley. 1999. Evidence that metastasis is less common in cirrhotic than normal liver: a systematic review of post-mortem case-control studies. Br. J. Surg. 86:1237-1242.
14. Uetsuji, S., M. Yamamura, K. Yamamichi, Y. Okuda, H. Takada, and K. Hioki. 1992. Absence of colorectal cancer metastasis to the cirrhotic liver. Am. J. Surg. 164: 176-177.
15. Utsunomiya, T., and T. Matsumata. 1993. Metastatic carcinoma in the cirrhotic liver. Am. J. Surg. 166: 776.
16. Lieber, M. 1957. The rare occurence of metastatic carcinoma in the cirrhotic liver. Am. J. Med. Sci. 233: 145-152.
17. Lisa, J., C. Solomon, and E. Gordon. 1942. Secondary carcinoma in cirrhosis of the liver. Am. J. Pathol. 18: 137-140.
18. Okuno, K., N. Hirai, Y. S. Lee, I. Kawai, H. Shigeoka, and M. Yasutomi. 1998. Involvement of liver-associated immunity in hepatic metastasis formation. J. Surg. Res. 75: 148-152.
19. Song, E., J. Chen, Q. Ou, and F. Su. 2001. Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am. J. Surg. 181: 529-533.
20. Utsunomiya, T., H. Saitsu, M. Saku, K. Yoshida, T. Matsumata, M. Shimada, and K. Sugimachi. 1999. Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus. Am. J. Surg. 177: 279-281.
21. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
22. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
23. Unanue, E. R. 1997. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158: 11-25.
24. Brockstedt, D. G., M. A. Giedlin, M. L. Leong, K. S. Bahjat, Y. Gao, W. Luckett, W. Liu, D. N. Cook, D. A. Portnoy, and T. W. Dubensky, Jr. 2004. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc. Natl. Acad. Sci. USA 101:13832-13837.
25. Hamon, M., H. Bierne, and P. Cossart. 2006. Listeria monocytogenes: a multifaceted model. Nat. Rev. Microbiol. 4: 423-434.
26. Portnoy, D. A., T. Chakraborty, W. Goebel, and P. Cossart. 1992. Molecular determinants of Listeria monocytogenes pathogenesis. Infect. Immun. 60: 1263-1267.
27. O'Riordan, M., C. H. Yi, R. Gonzales, K. D. Lee, and D. A. Portnoy. 2002. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. USA 99: 13861-13866.
28. Serbina, N. V., W. Kuziel, R. Flavell, S. Akira, B. Rollins, and E. G. Pamer. 2003. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 19: 891-901.
29. Samson, S. I., O. Richard, M. Tavian, T. Ranson, C. A. Vosshenrich, F. Colucci, J. Buer, F. Grosveld, I. Godin, and J. P. Di Santo. 2003. GATA-3 promotes maturation, IFN-γ production, and liver-specific homing of NK cells. Immunity 19: 701-711.
30. Auerbuch, V., D. G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D. A. Portnoy. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200:527-533.
31. Corbett, T. H., D. P. Griswold, Jr., B. J. Roberts, J. C. Peckham, and F. M. Schabel, Jr. 1975. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35:2434 -2439.
32. Jain, A., J. E. Slansky, L. C. Matey, H. E. Allen, D. M. Pardoll, and R. D. Schulick. 2003. Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Ann. Surg. Oncol. 10: 810-820.
33. Lauer, P., M. Y. Chow, M. J. Loessner, D. A. Portnoy, and R. Calendar. 2002. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184: 4177-4186.
34. Street, S. E., E. Cretney, and M. J. Smyth. 2001. Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97: 192-197.
35. Yoshimura, K., A. Jain, H. E. Allen, L. S. Laird, C. Y. Chia, S. Ravi, D. G. Brockstedt, M. A. Giedlin, K. S. Bahjat, M. L. Leong, et al. 2006. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Res. 66: 1096-1104.
36. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119-126.
37. Smyth, M. J., J. Swann, E. Cretney, N. Zerafa, W. M. Yokoyama, and Y. Hayakawa. 2005. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202: 583-588.
38. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746-4756.
39. Hokeness, K. L., W. A. Kuziel, C. A. Biron, and T. P. Salazar-Mather. 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174: 1549-1556.
40. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
41. Stetson, D. B., and R. Medzhitov. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24: 93-103.
42. Lee, C. K., D. T. Rao, R. Gertner, R. Gimeno, A. B. Frey, and D. E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165: 3571-3577.
43. Salazar-Mather, T. P., C. A. Lewis, and C. A. Biron. 2002. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J. Clin. Invest. 110: 321-330.
44. Smyth, M. J., J. Swann, J. M. Kelly, E. Cretney, W. M. Yokoyama, A. Diefenbach, T. J. Sayers, and Y. Hayakawa. 2004. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J. Exp. Med. 200: 1325-1335.
45. Neighbors, M., X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra. 2001. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon γ production. J. Exp. Med. 194:343-354.
46. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94: 634-639.